Status:
COMPLETED
Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Conditions:
Prematurity
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmenta...
Eligibility Criteria
Inclusion
- birth weight 400 to 1250 grams
- 24 0/7 to 30 6/7 weeks gestational age
Exclusion
- chromosomal, structural, metabolic, endocrine, or renal abnormalities that could affect growth
- infants \>18 hours of age
- infants in extremis who are unlikely to survive past 72 hours
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT01860573
Start Date
November 1 2008
End Date
December 1 2016
Last Update
April 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States, 02905